Ascendis Pharma A/S (ASND): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 2, 2026 | Smith Scott Thomas Officer | 100 | $219.00 | $21.9K | no history |
| Jun 1, 2026 | Bienaime Jean Jacques Director | 500 | $223.12 | $111.6K | no history |
| Jun 1, 2026 | Smith Scott Thomas Officer | 250 | $223.32 | $55.8K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.